Jinshan Biopharmaceutical

Fujian Jinshan Biopharmaceutical is a Chinese pharmaceutical and biotechnology company established in 1999 and headquartered in Fuzhou, Fujian Province. Operating as a key subsidiary of Fujian Jinshan Pharmaceutical Industrial Group, the company specializes in the research, development, manufacturing, and commercialization of small molecule therapeutics and biochemical drugs. Its commercial portfolio features a variety of small-volume injections, ointments, transdermal patches, and active pharmaceutical ingredients (APIs), including mecobalamin and cinepazide maleate. In addition to its established manufacturing capabilities, Fujian Jinshan Biopharmaceutical is advancing a research pipeline that includes innovative modalities such as antisense oligonucleotides targeting Bcl-2 for oncology indications. The company's production facilities are fully GMP-compliant, supporting its mission to deliver high-quality healthcare solutions across China.